Palvella Therapeutics, Inc.
Clinical trials sponsored by Palvella Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New gel could ease painful skin growths Results expected Aug 2027 (estimated)
-
New gel could treat painful skin vein bumps
Disease control OngoingThis phase 2 trial tests a gel containing sirolimus (PTX-022) on 15 people with visible venous malformations on the skin. The goal is to see if the gel is safe and can improve the appearance and symptoms of these abnormal veins. Participants apply the gel daily for 12 weeks, and …
Phase 2 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New gel could shrink rare skin bumps in kids and adults
Disease control OngoingThis phase 3 trial is testing a gel containing rapamycin (QTORIN 3.9%) for people aged 3 and older with microcystic lymphatic malformations, a rare condition causing fluid-filled bumps on the skin. About 40 participants will apply the gel daily for 24 weeks to see if it improves …
Phase 3 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC